0.40
-11.43%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About NewGenIvf Group
Its shares trade under the ticker NIVF. It has been listed since 15 February 2022. In the fiscal year to 31 December 2025, it reported revenue of $4.7m and net income of $9.9m. At that date it held total assets of $32.7m and shareholders' equity of $26.6m.
NewGenIvf Group Ltd is a SG-based company operating in industry. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The firm offers services, such as Mitochondrial Replacement Therapy In Reproductive, Intrauterine Insemination (IUI), Mitochondrial replacement therapy (MRT) techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular / epididymal sperm aspiration or extraction / percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. MRT involves an additional egg from a third person, and manipulating both the recipient egg and the donor egg.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 15 Feb 2022
- Head office
- 13/F, PS TOWER, SUKHUMVIT 21 RD (ASOKE), BANGKOK, W1, 0000
- Incorporated in
- D8
- Classification
- Services-Misc Health & Allied Services, NEC
- Filer status
- <br>Emerging growth company
Leadership
Pay as last reported
- Mr. Claudius TsangChairman of the Board, Chief Executive Officer, Chief Financial Officer, since 2021
- Mr. Abuzzal AbusaeriIndependent Director
- Mr. John BrebeckIndependent Director
- Mr. Giang Nguyen HoangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- NewGenIvf Group Ltd operates clinics in Thailand, Cambodia, and Kyrgyzstan for fertility services.
- The company offers comprehensive fertility treatments including IVF, ICSI, and MRT techniques.
- NewGenIvf provides full suite services like egg freezing, embryo transfer, and surrogacy in Asia.
Weaknesses
- The company has no clinics in Western countries for global fertility market access.
- NewGenIvf lacks services in genetic counseling for comprehensive patient care.
- The firm does not offer telemedicine options for remote consultations.
Opportunities
- Expanding into Japan and South Korea for Asian fertility market growth.
- Increasing demand for MRT techniques in Southeast Asia.
- Partnering with hospitals in Vietnam for additional fertility services.
Threats
- Regulatory changes in Cambodia affecting fertility services.
- Competition from local clinics in Thailand's growing market.
- Economic downturns in Kyrgyzstan impacting patient affordability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.